KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Deferred Taxes (2016 - 2025)

Teladoc Health's Deferred Taxes history spans 12 years, with the latest figure at -$10.0 million for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 467.08% year-over-year to -$10.0 million; the TTM value through Dec 2025 reached -$41.4 million, down 3516.33%, while the annual FY2025 figure was -$41.4 million, 3516.33% down from the prior year.
  • Deferred Taxes for Q4 2025 was -$10.0 million at Teladoc Health, down from $2.6 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $87.0 million in Q1 2021 and bottomed at -$49.6 million in Q4 2021.
  • The 5-year median for Deferred Taxes is -$1.8 million (2022), against an average of -$524750.0.
  • The largest annual shift saw Deferred Taxes skyrocketed 3185.25% in 2021 before it plummeted 1579.06% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$49.6 million in 2021, then soared by 96.17% to -$1.9 million in 2022, then soared by 350.53% to $4.8 million in 2023, then tumbled by 136.93% to -$1.8 million in 2024, then tumbled by 467.08% to -$10.0 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Deferred Taxes are -$10.0 million (Q4 2025), $2.6 million (Q3 2025), and -$7.2 million (Q2 2025).